Thailand Jetanin Hospital Third-Generation IVF Technology Assessment & Real Consultation Analysis
Real consultation scenario opening
Last week, I met a couple from Beijing at the fertility clinic. The wife was 38 years old with an AMH of 1.2 ng/mL, and the husband's routine semen analysis was essentially normal. They came with a thick stack of documents and got straight to the point: "We want to go to Thailand Jetanin Hospital for third-generation IVF. Is the success rate higher? Is our situation suitable?" This question is very representative, involving multiple dimensions for judgment, including technical indications, hospital selection logic, and individual physical condition.
Core Value and Applicable Boundaries of Third-Generation IVF
Direct Answer: Thailand Jetanin Hospital has the laboratory conditions and technical capabilities to perform third-generation IVF (PGT-A, PGT-M, PGT-SR), but whether it is "good" depends on the specific medical condition of the patient. Third-generation IVF is not an "upgraded version" of the standard procedure, but a precise solution for specific problems.
Doctor's Clinical Reasoning: The core value of third-generation IVF lies in screening for chromosomal aneuploidy (PGT-A), monogenic diseases (PGT-M), or chromosomal structural rearrangements (PGT-SR) before embryo implantation, thereby reducing miscarriage rates and preventing the transmission of genetic diseases. Without these medical indications, third-generation IVF does not improve the live birth rate and may instead reduce the number of transferable embryos due to embryo loss during blastocyst culture and biopsy.
Therefore, the first step in determining "whether third-generation IVF at Jetanin Hospital is suitable for you" is not to compare hospitals, but to first clarify whether you and your partner have medical indications that require PGT intervention.
Standard Process and Timeline for Third-Generation IVF at Jetanin
Completing a full third-generation IVF cycle at Jetanin Hospital typically involves the following steps, with the overall cycle taking about 2 to 3 months (excluding preliminary preparation):
| Stage | Specific Content | Estimated Time |
|---|---|---|
| ① Initial Consultation & Assessment | Complete basic fertility tests domestically (AMH, FSH, LH, antral follicle count, semen analysis), then consult with the doctor remotely or in Thailand to develop a plan. | 1–2 weeks |
| ② Ovarian Stimulation | Choose a stimulation protocol based on ovarian reserve, with regular monitoring of follicle development and hormone levels. | 10–14 days |
| ③ Egg Retrieval & Fertilization | Ultrasound-guided egg retrieval, ICSI fertilization, and observation of fertilization status. | 1 day |
| ④ Blastocyst Culture & Biopsy | Embryos are cultured to the blastocyst stage (day 5–6), followed by trophectoderm cell biopsy (3–5 cells). | 5–6 days |
| ⑤ Genetic Testing | PGT-A (chromosomal aneuploidy screening) or PGT-M (monogenic disease testing), report generation. | 2–4 weeks |
| ⑥ Frozen Embryo Transfer | Endometrial preparation (natural cycle or hormone replacement cycle), transfer of genetically normal embryos. | 3–5 weeks |
Materials to Prepare in Advance: Valid passports for both spouses (valid for at least 6 months), notarized and translated marriage certificate, and medical reports from a domestic tertiary hospital within the last 3–6 months (infectious disease screening, karyotype, AMH, semen analysis, etc.). Some test results have expiration dates, so it is advisable to confirm each item with the medical coordinator before departure.
Impact of Age and Ovarian Reserve on Third-Generation IVF
The success rate of third-generation IVF is highly dependent on obtaining a sufficient number of blastocysts for biopsy and screening, with age and ovarian reserve being the core factors determining blastocyst yield.
- • ≤35 years old: Relatively higher number of eggs retrieved and blastocyst formation rate, with an aneuploidy rate of about 30%–40%. If there are indications such as genetic disease carrier status or recurrent miscarriage, the benefit of third-generation IVF is clear.
- • 36–40 years old: Both the number of follicles and the embryo euploidy rate decrease significantly, with the aneuploidy rate rising to 50%–60%. PGT-A can effectively screen for chromosomally normal embryos, reducing the risk of miscarriage.
- • ≥41 years old: The aneuploidy rate can reach 70%–80%. Even if blastocysts form, the proportion of normal ones is very low. It is necessary to fully assess the expected egg yield and the risk of blastocyst culture failure to avoid a situation of "no embryos available for transfer."
- • AMH < 0.5 ng/mL: Severely diminished ovarian reserve. The number of eggs retrieved per cycle is typically ≤3, and the probability of forming blastocysts is low. Entering a third-generation IVF cycle directly in such cases may result in an insufficient number of blastocysts to complete biopsy and testing. It is recommended to first conduct an ovarian function assessment and a trial stimulation cycle to predict response.
Characteristics of Individuals Who Truly Need Third-Generation IVF
Third-generation IVF is a targeted medical technology, not a mandatory choice for everyone undergoing IVF. The following situations may warrant consideration:
Suitable Candidates
- Female age ≥ 38 years with ≥ 2 recurrent miscarriages
- One partner carries a chromosomal structural abnormality (e.g., translocation, inversion)
- Diagnosed with a monogenic disease (e.g., thalassemia, spinal muscular atrophy)
- Recurrent implantation failure (≥ 3 transfers of good-quality embryos without pregnancy)
- Previous birth of a child with a chromosomal abnormality
- Severe male factor (e.g., high sperm DNA fragmentation, assessed in conjunction with PGT-A)
Unsuitable or Requiring Caution
- Very low ovarian reserve (AMH < 0.5), with an expected egg yield of ≤ 2
- Solely for sex selection without other medical indications (though legal in Thailand, ethical evaluation is needed)
- Extremely low blastocyst formation rate (≥ 2 previous failed blastocyst cultures)
- Young women (< 35 years) with normal chromosomes and no genetic disease history – third-generation IVF does not increase live birth rate
- Genetic issues that PGT cannot address (e.g., mitochondrial diseases, polygenic disorders)
Easily Overlooked Preparations
Overseas IVF involves cross-border medical coordination, and insufficient preparation of details is a major cause of cycle delays:
- Passport Validity: Thailand requires a passport validity of at least 6 months upon entry. Check this before departure. If renewal is needed, apply at least 3 months in advance.
- Test Report Validity: Karyotype analysis is valid for life, but infectious disease screening (HIV, Hepatitis B, Syphilis, etc.) is valid for 3–6 months. AMH and semen analysis should ideally be repeated within 3 months.
- Pre-Genetic Counseling: If PGT-M is planned for a monogenic disease, the pathogenic gene mutation site must be identified first, and family verification completed. This process takes 4–8 weeks and must be finished before starting the cycle.
- Male Partner Evaluation is Equally Crucial: Tests like semen analysis, sperm DNA fragmentation, and Y-chromosome microdeletion are often overlooked but directly impact fertilization method and embryo development.
- Endometrial Preparation: The uterine cavity environment needs assessment before transfer. It is recommended to complete a hysteroscopy before the stimulation cycle or after egg retrieval to rule out polyps, adhesions, or endometritis.
- Medication Carriage & Customs Declaration: Stimulation medications must be carried with a prescription. It is advisable to prepare an English doctor's note to avoid customs delays.
- Visa & Itinerary Planning: A medical visa (typically 60 days) can cover the stimulation + egg retrieval + embryo testing period. However, a second transfer may require an additional trip.
Common Decision-Making Misconceptions
Misconception 1: "Third-generation IVF has a higher success rate than second-generation, so just go with the third."
Third-generation IVF does not improve fertilization or blastocyst formation rates; its value lies in screening. For young women without genetic indications, third-generation IVF does not increase the live birth rate per single transfer.
Misconception 2: "As long as I have PGT-A, I won't have a miscarriage."
PGT-A only screens for chromosomal aneuploidy and cannot detect issues like small segment deletions, uniparental disomy, or mosaicism. Miscarriage causes are complex and include immune, coagulation, and uterine structural factors.
Misconception 3: "Third-generation IVF at Thai hospitals is more expensive, so the outcome must be better than in my home country."
Hospital selection should be based on laboratory quality control, the degree of individualized clinical protocols, and how well they match your specific condition. Many domestic fertility centers also have mature PGT technology; the differences lie in the process experience and certain policy restrictions.
Misconception 4: "Embryo biopsy harms the embryo and reduces implantation rates."
The current mainstream technique is trophectoderm biopsy (taking 3–5 cells), which is separated from the inner cell mass and has a limited impact on embryo developmental potential. Global cumulative data show no significant difference in implantation rates between biopsied euploid embryos and non-biopsied blastocysts.
Frequently Asked Questions
Q: Can I still do third-generation IVF at Jetanin if my AMH is low?
A low AMH does not mean it's completely impossible, but you need to be mentally prepared for a low egg yield. If AMH < 0.5, it is advisable to first try one stimulation cycle to assess egg retrieval potential before deciding to proceed with the third-generation process. Typically, at least 3–4 blastocysts are needed to have a reasonable chance of obtaining one euploid embryo.
Q: How long does it take to prepare before starting a third-generation IVF cycle?
If basic tests are complete and genetic counseling is done, it takes about 4–6 weeks from the initial consultation to officially starting the cycle. It is recommended to start taking folic acid or multivitamins, quit smoking, limit alcohol, and maintain a regular routine 3 months in advance. Male partners are also advised to adjust their lifestyle 3 months prior, as the sperm formation cycle is about 72 days.
Q: How many trips to Thailand are needed for third-generation IVF at Jetanin?
Typically, at least two trips are required. First trip: initial consultation + stimulation + egg retrieval (about 15–18 days). Second trip: endometrial preparation + transfer (about 7–10 days). If frozen embryo transfer is chosen and the cycles align smoothly, the interval between the two trips is 1–2 months.
Q: How long does it take to get the genetic test results for third-generation IVF?
The PGT-A testing period is usually 2–3 weeks, while PGT-M or PGT-SR may take 3–4 weeks. After testing, embryos are cryopreserved until the transfer cycle, when they are thawed for use. Embryo cryopreservation does not affect the thaw survival rate.
Risk Reminder
- Third-generation IVF cannot guarantee 100% normal embryos. Some patients may face a result of "no euploid embryos available for transfer," especially those of advanced maternal age or with low ovarian reserve.
- PGT-A has a misdiagnosis rate of about 1%–2% (due to mosaicism, confined placental mosaicism, etc.). It is recommended to confirm results with amniocentesis or chorionic villus sampling after pregnancy.
- Cross-border medical care involves language communication, legal agreements, and fee settlement. It is advisable to choose a reputable medical coordination agency or communicate directly with the hospital's international department to avoid information asymmetry.
- All medical decisions should be made under the joint guidance of a reproductive specialist and a genetic counselor. Do not make judgments based solely on online information.
As a reproductive specialist, a common phenomenon I observe is that many patients focus too much on "which hospital to choose" while neglecting the decisive role their own baseline conditions play in success. Jetanin Hospital is a technologically mature fertility center in Thailand, but whether one truly benefits from third-generation IVF still depends on – whether there are clear medical indications, whether the embryo count is sufficient, and whether the couple has a full understanding of the test results and potential risks.
